
A study investigated the impact of prophylactic antenatal corticosteroids (ACS) on maternal blood glucose (MBG) in gestational diabetes mellitus (GDM). Among 52 patients, 12 initiated insulin, 14 were already on it, and the rest managed with medical nutritional therapy (MNT). MBG declined from day 3, reaching euglycemia by day 4. Insulin requirements varied significantly. No fetal loss occurred. The study concludes that ACS-induced hyperglycemia necessitates insulin or oral hypoglycemic agents, and well-controlled glycemic status is attainable through MNT and pharmacotherapy with continuous monitoring.
Like
Save
Share